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Post Myocardial Infarction Risk Stratification: 1991 Perspective 
Michael Lesch, MD' 
The prospective identification of subsets of post myocardial infarction (MI) patients at risk for increased cardiac mortal-
ity or morbidity has been termed "post-MI risk stratification." 
By virtue of the research effort devoted to this topic, a number of 
risk stratification variables have been identified and utilized to 
develop management strategies for post-MI patients. Definition 
of these techniques and strategies represents significant accom-
plishment, yet algorithms capable of defining specific risk cate-
gories in individual patients have yet to be developed. This goal 
remains the objective of much research because the need to de-
velop improved risk stratification strategies is pressing and ap-
parent from a number of perspectives. 
Achievement of accurate stratification methodologies would 
allow for: I) improved post-MI care with resultant decreased 
mortality and morbidity; 2) cost-efficient care (targeting expen-
sive therapies and/or diagnostic techniques to populations like-
ly to benefit from them); 3) rapid identification of different 
pathophysiologic mechanisms that could guide specific ther-
apy; 4) cost-efficient treatment trials since smaller numbers of 
patients would need to bye enrolled in cooperative protocols if 
endpoint incidence could be predicted more accurately; and 5) 
the development of post-MI care guidelines for different patient 
subsets based upon hard data, thus alleviating arbitrary regula-
tory mechanisms presently utilized by third-party bodies to con-
trol costs. 
The impetus to develop post-MI risk stratification strategies 
developed soon after research in the coronary care unit (CCU) 
identified strategies capable of defining in-hospital morbidity 
and mortality for the MI patient (1,2). Most studies of in-hospi-
tal mortality and morbidity also observed increased mortality in 
post-MI patients in the period following discharge from the hos-
pital regardless of apparent patient status (3-7). When control-
ling for all known predictors of mortality and morbidity in coro-
nary disease (ventricular function, symptomatic state, presence 
of congestive heart failure, and arrhythmia status), a comparison 
of patients with chronic stable coronary disease to matched con-
trols who were 0 to 18 months post MI revealed that the latter 
group experienced significantly increased mortality and mor-
bidity. This single factor—the inordinately high morbidity and 
mortality of the immediate post-MI period—stands as the epi-
demiologic imperative defining the necessity to develop im-
proved post-MI risk stratification strategies. The early post-MI 
period is a perilous interval for the patient with coronary disease 
and offers a window of opportunity in which finite benefit can 
be provided to this patient population. Thus, while risk stratifi-
cation has been a continuous theme of research in coronary ar-
tery disease for many years, the realization that the post-MI state 
carries added risk for the coronary patient has served to focus at-
tention on this particular time period. 
The importance of defining quantifiable variables capable of 
predicting risk not only in defined populations but also in indi-
vidual patients was widely recognized by the mid 1970s, receiv-
ing particular impetus from the work of Arthur Moss (8) at the 
University of Rochester, NY, and J. Thomas Bigger (9) of Co-
lumbia University. The current post-MI risk stratification litera-
ture is too large to be reviewed comprehensively in a single arti-
cle. Therefore, this article will focus on the following aspects of 
the risk stratification literature; 1) current concepts of post-MI 
risk stratification, 2) methodologies used to stratify risk with 
particular emphasis on problems inherent to such methodolo-
gies, and 3) specific problems regarding the application of post-
MI risk stratification studies to clinical practice. 
Post-MI Risk Stratification: 
Current State of the Art 
In 1987, Moss et al (7) observed in their review that six major 
pathophysiologic considerations formed the conceptual frame-
work for post-MI risk stratification: 1) infarct size, 2) ventricular 
function, 3) ventricular arrhythmias, 4) anginal status, 5) stress 
testing, and 6) coronary angiography. While new techniques rel-
evant to these six parameters have been introduced since 1987, 
they can be analyzed within the format of the 1987 article with a 
few notable exceptions. Thus, dipyridamole perfusion imaging 
with thallium can be considered a variant of stress testing while 
the signal-averaged ECG and analysis of heart rate variability 
can be considered new methods for assessing the potential for 
serious ventricular arrhythmia. Conversely, the potential role of 
silent ischemia, thrombolytic therapy, and the concept of patent 
infarct-related arteries as determinants of post-MI risk are not so 
easily accommodated within the conceptual context of the 1987 
article. The original Moss-Bigger-Odoroff format witi thus be 
utilized herein to present currently available data with addi-
tional headings added as necessary to accommodate post-1987 
concepts. 
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Infarct size 
The importance of infarct size in determining MI prognosis 
was initially established from autopsy studies of patients with 
cardiogenic shock or pump failure. These quantitative patho-
logic studies correlated pump failure to the total amount of ne-
crotic myocardium, demonstrating that pump failure occurred 
when more than 40% of the left ventricle had become infarcted. 
Moreover, the timing of such necrosis was found not to be of im-
portance (e.g., a single recent episode causing infarction of 40% 
of the left ventricle was equivalent to an old 20% infarct and a 
recent 20% infarct) (10-12). Recognition of the importance of 
infarct size as a determinant of survivorship prompted investi-
gation of techniques for measuring infarct size in vivo in acute 
Ml patients. The original goal of measuring infarct size pre-
cisely and accurately in units of mass of infarcted myocardium 
was not fully realized as the complexity of measuring infarct 
size became apparent (13). However, while precise measure-
ment of infarct size might not be possible, semi-quantitative es-
timation of relative infarct size was feasible (14). When these 
techniques for semi-quantitative estimation of infarct size were 
used to stratify risk in surviving MI patients, an unequivocal re-
lationship between infarct size and mortality (both early and 
late) was established (7,14,15). This relation remains the key-
stone of risk stratification to this day. Issues conceming infarct 
size that have not been definitively dealt with to date despite sig-
nificant discussion in the literature relate to the equivalency of 
equally sized infarcts in determining post-MI risk, when infarcts 
are subcategorized as to type (Q wave versus non-Q wave in-
farcts) (16,17), location (anterior versus inferior) (18), or spe-
cific electrophysiologic effect (heart block, conduction distur-
bance, etc.) (19,20). 
Ventricular function 
Post-MI ventricular function, ostensibly a surrogate measure-
ment of infarct size, has been directly measured both invasively 
(21) and noninvasively (22) as well as indirectly estimated by 
a variety of techniques ranging from clinical examination (23) 
to chest x-ray analysis (24) to an ECG scoring system (25). The 
pathologic data referenced above (10-12) have been evaluated 
relative to ventricular function in survivors of acute MI and 
summarized by Fetch (26) as follows: 
"There is a good reladonship between the amounl of lefl 
ventricular damage and the resulling physiology; less 
lhan 10% loss and there is merely some reduction in left 
ventricular ejection fraction. 15% loss is associated wilh 
elevalion of filling pressure. 25% loss resulls in clinical 
cardiac failure, and 40-50% resulls in cardiogenic shock," 
Despite the multiplicity of techniques available for the post-
MI estimation of left ventricular (LV) function and the numer-
ous time points during and after hospitalization at which such 
determinations could be made, multiple-gated image acquisi-
tion (MUGA) measurement of ejection fraction predischarge 
has achieved de facto "gold standard" status as the technique of 
choice. This status presumably derives from two factors: the 
landmark data obtained from MUGA ejection fractions as re-
ported by the Multicenter Postinfarction Research Group (22) in 
1983, and the combined widespread availability and ease of re-
producibility of this technique. 
The landmark 1983 study (22) demonstrated a curvilinear re-
lationship between one-year post-MI cardiac mortality and pre-
discharge MUGA ejection fractions (Figure). While mortality 
was minimally increased at decreasing levels of ejection frac-
tion down to the 40% range, a dramatic increase in mortality was 
noted at ejection fraction levels below 35%. All studies pub-
lished on this topic, regardless of methodology utilized to mea-
sure LV function, confirm this general conclusion (7,21). Al-
though discrepancies may exist as to what specific numerical 
value for risk should be attributed to any given degree of ven-
tricular dysfunction, the general curvilinear relationship be-
tween decreased ventricular function and increased post-MI 
mortality is accepted as fact. 
Arrhythmia analysis 
Attempts to predict the risk for subsequent ventricular ar-
rhythmia (ventricular tachycardia/ventricular fibrillation [VT/ 
VF]) and sudden cardiac death in post-MI subsets based upon 
analysis of ambulatory ECG recordings were derived from early 
CCU experience. The latter demonstrated ventricular ectopic 
activity (VEA) to be a harbinger of more advanced forms of ven-
tricular arrhythmia (VTA'F) in the setting of acute infarction 
and that pharmacologic suppression of this VEA significantly 
reduced the occurrence rate of VTA'F (17). To hypothesize that 
VEA occurring in the post-hospital phase of coronary artery dis-
ease might have similar significance and that chronic anti-
arrhythmic therapy might have similar beneficial effect seemed 
reasonable and a logical extension of known fact at the time 
(27). Consequently, numerous centers tested the first half of this 
hypothesis by obtaining pre or post discharge ambulatory ECGs 
of various duration in MI patients and correlating the ECG data 
vis-a-vis VEA to post-MI endpoints (usually sudden cardiac 
death) (28). Although it appeared evident that the presence of 
VEA was statistically associated with increased risk for subse-
quent cardiovascular morbidity, consensus could not be reached 
regarding the precise quantitative implication of VEA. The in-
ability to define with great precision the implications of VEA in 
the post-MI period was to a significant degree related to two spe-
cific issues. First, there was no quantitative grading system for 
VEA which accounted for both arrhythmia frequency and sever-
ity (29). No techniques existed then or now which would allow 
for assessment of a single run of 3 beat VT on a 24-hour tape as 
compared to one demonstrating five unifocal premature ventric-
ular contractions per minute in each minute of the day. One is 
more "severe," the other is more "frequent." The question of 
which, if either, carries greater prognostic significance remains 
unanswered. Second, data accumulated indicating that VEA 
was not an independent marker of adverse prognosis, but rather 
a dependent variable related primarily to compromised ventric-
ular function (30-34). Numerous studies of the correlation be-
tween LV dysfunction and VEA supported the concept that 
VEA was a surrogate marker of myocardial scar and thus ven-
tricular dysfunction. Moss et al (7) addressed this issue and ex-
amined the data base from two large MI studies wherein both 
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Figure—Cardiac mortality rate in four categories of radionu-
clide ejection fr action determined before hospital discharge 
after myocardial infarction. (From the Multicenter Postinfarc-
tion Research Group. Risk stratification and survival after myo-
cardial Infarction. New Engl J Med 1983 ;309;331-6. Reprinted 
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LV function and VEA had been tabulated as a function of post-
MI mortality. They concluded that repetitive VEA (> 10 prema-
ture ventricular beats/hour) was strongly correlated to mortality 
even after adjusting for LV dysfunction. VEA and LV dysfunc-
tion were shown in this analysis to be independent contributors 
to post-MI mortality, with the predicted mortality for a patient 
with both VEA and LV dysfunction being greater than the arith-
metic sum ofeach individual risk factor. In other words, the two 
risk factors positively interacted. 
Attempts to use "stress testing" as a modality to expose latent 
risk for arrhythmic death in post-MI populations have been dis-
appointing. Treadmill testing to induce arrhythmia in the exer-
cise state (7,35) (also see section entitied Exercise Testing) has 
not provided improved prognostic indices in the post-MI pa-
tient. Initial experiences with electrophysiologic testing to in-
duce arrhythmia with different stimulation protocols indicated 
this technique was of marginal value in predicting the likelihood 
of subsequent arrhythmia in the post-MI population (7,36). Re-
cent experiences have demonstrated greater predictive value for 
the technique (37,38), although the failure of this methodology 
to gain wider clinical acceptance within the cardiology commu-
nity at large represents indirect support for the skepticism ex-
pressed in an editorial review (39) of one of these latter (38) pub-
lications. 
Two new methodologies not based upon the presence, ab-
sence, or inducibility of VEA have recentiy drawn attention as 
techniques potentially capable of predicting risk of VT/VF in 
post-MI populations. The "signal-averaged ECG" takes advan-
tage ofthe observation that direct intraoperative epicardial elec-
trograms, obtained at or near foci of spontaneous VTA'F gener-
ation in patients undergoing mapping studies, reveal fractiona-
tion ofthe terminal portion of the QRS, implying some form of 
disordered impulse conduction at those sites. This fractionation 
is not discemible with routine surface ECGs due to the very low 
signal-to-noise ratio inherent to ECG signals in this portion of 
the QRS complex. These observations stimulated development 
of a technology to evaluate dispersion of terminal QRS forces 
from surface ECGs by subjecting surface ECG data to "signal 
averaging" so as to amplify the low voltage signals of interest. 
While some initial reports suggest that an abnormal signal-aver-
aged ECG in the post-MI period may be predictive of subse-
quent risk for VTAF, many details with this approach need to 
be worked out before it can be considered clinically useful (40-
45). 
Analysis of heart rate variability is a second, ambulatory 
monitor-based, non-VEA-dependent methodology presently be-
ing evaluated as a post-MI risk stratification variable (46-48). 
This technique takes advantage of the observation that normal 
cardiovascular function is characterized by a rather large varia-
tion in heart rate throughout the day. Conversely, progressive 
degrees of impaired cardiovascular function, and thus presum-
ably increased risk for sudden cardiac death, is characterized by 
decreased heart rate variability. This technique, like the signal-
averaged ECG, may hold significant promise as a risk stratifica-
tion variable. However, the two techniques share the common 
drawback of not yet having been studied adequately for this pur-
pose to be of proven clinical utility. 
Postinfarction angina 
The long-term prognostic implication of anginal syndromes 
in the immediate post-MI phase is not likely to be investigated 
further given recent conceptual changes regarding our under-
standing of the mechanisms operative in the pathophysiology of 
postinfarction angina and infarction (49,50), the introduction of 
thrombolytic and anticoagulant therapy (51), the widespread 
availability of percutaneous transluminal coronary angioplasty, 
and the commonly held precept that postinfarction angina im-
plies tbe need for revascularization therapy (52,53). In the cur-
rent therapeutic climate, the pressure to treat post-MI ischemia 
manifesting as anginal pain is so overwhelming that a controlled 
study designed to analyze the prognostic implication of angina 
in the immediate post-MI period is not feasible. The consensus 
that MI patients who manifest early post-MI ischemia are at 
greater risk than those without such manifestations is based 
upon considerable experience and probably should be accepted. 
Exercise stress testing 
The specificity and sensitivity of exercise stress testing using 
the ECG, LV function analysis, or perfusion scanning either sin-
gly or in combination for the detection of coronary artery dis-
ease have been well delineated (54-58). Although the sensitivity 
and specificity of these techniques are far from perfect and the 
precision and accuracy with which they can predict future mor-
bid events are even less perfect, data derived from these tests 
have been developed into meaningful algorithms for evaluation 
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ofthe patient with stable ischemic heart disease. In patients with 
stable documented or suspected coronary disease, the utility of 
stress testing is largely due to the use of standardized protocols 
for test performance and interpretation. A similar degree of 
"standardization" is not available in post-MI stress testing. Dif-
ferent centers utilize different exercise protocols and endpoints 
and perform the test at different times post-MI, thus making it 
impossible to develop any general statement about this proce-
dure. As exemplified by a number of recent publications, not 
much consensus exists as to what specific endpoints in what 
specific protocols have what specific implication in the post-MI 
population at large (59-64). While there appears to be some 
agreement that ST segment depression is not as important an 
endpoint and that evidence of LV dysfunction (maximum meta-
bolic equivalents achieved, blood pressure response) is more 
important as compared to similar testing in chronic stable popu-
lations, post-MI stress testing remains a commonly used proce-
dure in clinical practice which remains incompletely defined 
and characterized. 
Coronary angiography 
The pattem of the progression of coronary atherosclerosis 
was initially defined from serial angiographic analysis. The ma-
jor conclusion derived from these studies which analyzed retro-
spectively populations of patients who had undergone angiogra-
phy on at least two occasions for diverse reasons was that pro-
gression of coronary atherosclerosis is unpredictable (65-67). In 
these studies high-grade lesions frequentiy were found to be sta-
ble over many years while total occlusions developed within a 
short term at sites which had been normal or minimally diseased 
at the time of initial study. This observation was confirmed pro-
spectively in a post-MI population by Littie et al (68). These in-
vestigators performed angiography on a Ml population at or 
around the time of the index MI. Those patients not subjected to 
revascularization procedures who sustained a subsequent MI 
were submitted to repeat angiography at the time of the second 
event to define the culprit lesion and/or infarct-related artery of 
the second event. The data indicated that the vascular site re-
sponsible for the second MI could not be predicted on the basis 
of lesion anatomy defined by the angiogram performed immedi-
ately after the first MI. 
These puzzling data went unexplained until Davies and oth-
ers (49-51) demonstrated, using pathologic technique and anal-
ysis, that the rapid deterioration (development of infarction or 
an unstable anginal syndrome) of a patient with previously sta-
ble coronary atherosclerosis was due not to progression of the 
atherosclerotic process but to the rupture of the fibrous cap over-
lying atherosclerotic lesions and the subsequent formation of to-
tal or subtotal occlusive thrombotic plugs at the mpture site as 
blood was exposed to the thrombogenic infiuence of the lipid 
and collagen which comprise the bulk of an atherosclerotic le-
sion. It was further demonstrated that the likelihood of fibrous 
cap mpture was not related to the initial degree of lesion sever-
ity, thus explaining the previously enigmatic "random" progres-
sion of coronary atherosclerosis. 
In view of these considerations, coronary angiography is best 
conceptualized as a technique for evaluating the anatomic status 
ofthe coronary arterial tree at a given point in time. It offers little 
in the way of predictive capability regarding either the site or 
rate of disease progression and is thus of limited value as a pre-
dictive post-MI risk stratification variable. 
New concepts 
The majority of available post-MI stratification data predate 
the widespread use of thrombolytic therapy. It is unclear if pres-
ently held concepts regarding stratification need to be modified 
in the thrombolytic era. One concept emanating from the throm-
bolytic experience that may significantly impact stratification 
studies and strategies is that of the "patent infarct-related artery" 
(69). In some patients where thrombolysis is achieved, it occurs 
too late to salvage any myocardium. Patients left with such an 
infarct and a patent infarct-related artery experience fewer epi-
sodes of death and/or sudden cardiac death following infarction. 
Patients with a given mass of infarcted tissue and a patent in-
farct-related artery are less likely to have electrophysiologic 
findings associated with an increased risk for sudden cardiac 
death (70-76) compared to patients with an occluded infarct ar-
tery. If these findings are substantiated, the implication for the 
rouline management of post-MI patients will be profound. Such 
substantiation would justify attempts to open infarct-related ar-
teries, even after infarction has occurred, with thrombolytic or 
mechanical approaches. 
A second emerging concept relative to post-MI stratification 
relates to the general topic of silent ischemia (77,78). The signif-
icance and relevance of silent ischemia is presentiy being eval-
uated in numerous subsets of coronary disease patients, and a 
firm statement relative to post-MI stratification would be pre-
mature. What is apparent at this juncture, however, is that isch-
emia, be it painful or painless, is of definite significance in pa-
tients with coronary disease. Whether these two syndromes are 
of "equal" significance and prognostic importance remains to 
be determined. 
Methodologic Problems Inherent to 
Post-MI Risk stratification Studies 
All risk stratification studies test the general hypothesis that a 
particular study parameter (e.g., LV function, arrhythmia status, 
heart rate variability, exercise tolerance), when measured at 
some defined time point (e.g., on admission to CCU, before 
CCU discharge or at hospital discharge), defines subset groups 
within a large MI patient population with different risks for cer-
tain predetermined endpoints (e.g., death, sudden cardiac death, 
reinfarction, unstable angina, or need for revascularization sur-
gery). Patient populations used for these studies have been ob-
tained retrospectively (79), prospectively (80), or by a combina-
tion approach with retrospective analysis of a data base obtained 
from MI patients studied for some other protocol (7). 
In recent years clinical investigators have become sensitive to 
(and more sophisticated with) statistical issues in clinical re-
search. Accordingly, most post-MI risk stratification studies 
demonstrate considerable expertise regarding both the statisti-
cal definition of the Ml population(s) studied, the data to be ana-
lyzed, and the techniques utilized for analysis. Despite the vig-
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orous statistical techniques applied to post-MI risk stratification 
studies, conclusions drawn from such studies remain potentially 
inaccurate due to the very nature of the problem being studied. 
All attempts to study post-MI risk stratification, no matter 
what inclusion/exclusion criteria are used to construct the study 
group(s), perforce make the assumption that the study group(s) 
is(are) statistically identical. This assumption requires that the 
Ml population be homogeneous or, if heterogeneous, that the 
statistical variation raised by such heterogeneity can be over-
come by studying increased numbers and thus "averaging out" 
any differences. The probability that these requirements can be 
achieved is questionable. 
The inherent, complex heterogeneity of the MI patient popu-
lation and the potential fallacy behind the strategy of averaging 
out hidden differences between such populations by studying 
large numbers of patients have been previously discussed by 
Kelly (81) who states: 
"A further caveat is that, while management and treat-
ment in our conlemporary medical limes is deiermined by 
the response of a large series of patients in controlled tri-
als, physicians treat individuals, and it is he or she who 
must have risk determined, investigated, and ireated ap-
propriately. Although most series, and panicularly those 
evaluating treatment following myocardial infarction, 
contain large numbers of patients, il is important and can-
not be emphasized strongly enough that these patients 
represent the pooled dala base of patients of diverse ages, 
disease states, and thus prognosis. While such informa-
lion from these .studies is valuable, myocardial infarction 
is not a homogeneous enlity. ll is complex and heteroge-
neous and this again emphasizes that the physician must 
evaluate each individual patient." 
Issues such as differences in age, sex, number of previous in-
farcts, infarct location, and infarct type (Q wave versus non-Q 
wave) are further discussed by Kelly (81). Topics which are 
more complex and are not discussed, thus posing greater statisti-
cal methodologic challenges, include the following: 
1. In studies of patients with first Mls, the historical presence/ 
absence of angina is frequently tabulated, but the clinical and 
temporal pattem of the angina is usually not. Two patients with 
a first MI and a history of angina will be inappropriately consid-
ered statistically identical even if in one the anginal pattem was 
of a chronic stable type of five years' duration while in the sec-
ond there was a five-day history of acute onset unstable angina. 
2. In patients with second Mls, how should the duration be-
tween the historical Ml and the index MI be dealt with? Should 
one consider patients with a second Ml to be statistically identi-
cal ifthe duration between Mls is two weeks versus two months 
versus two years versus two decades? 
Many more examples of true infarct population heterogene-
ity, despite apparent statistical homogeneity, could be provided. 
The issue to recognize is that just as there exists no American 
family with 2.3 children and 1.7 parents living at home, there ex-
ists no average infarct patient. The concept of an average infarct 
population, while scientifically valid in the statistical sense for 
analysis of population subsets, suffers from an inability to mod-
el adequately the multiple complexities of the infarct population 
so as to make comparisons between a given individual patient 
and the average population valid. Altematively stated, our in-
ability to define all pertinent patient variables when attempting 
to study post-MI risk stratification results in our statistical ap-
proach being inadequately "robust." 
A second methodologic problem inherent to all post-MI risk 
stratification studies is best described as "endpoint ambiguity." 
The term ambiguity is used because death, reinfarction and/or 
the development of angina, or the need for revascularization are 
commonly used as endpoints in post-MI risk stratification stud-
ies. The use of such endpoints mandates the assumption that the 
particular endpoint under consideration either results from, is 
directiy caused by, or is an immediate complication of the index 
MI, i.e., the Ml which caused the patient to be entered into the 
study in the first place. Because coronary atherosclerosis tends 
to be a progressive disease, such progression is not necessarily 
limited to the infarct-related artery of the index MI, and progres-
sion in non-infarct-related arteries can also result in death, rein-
farction and/or the development of angina, or the need for revas-
cularization, and thus ambiguity results. If a subject in a post-
MI risk stratification study experiences sudden death six to 12 
months post-MI, how can it be determined whether that episode 
of sudden cardiac death was mediated by the scar and/or resul-
tant ischemia related to the index infarct as opposed to progres-
sion of atherosclerosis and/or acute thrombotic occlusion of a 
remote non-infarct-related artery? The death, while considered a 
hard endpoint for the study, is nonetheless an ambiguous end-
point since it cannot definitely be considered as a complication 
of the original infarct. 
Future Challenges: Statistical Significance 
Versus Clinical Importance 
This review has attempted to analyze for the clinician the 
present status of post-MI risk stratification. The obvious conclu-
sions from the material presented are that, statistically speaking, 
the worse the LV function, the greater the degree of arrhythmia 
or potential for arrhythmia, and the greater the degree of residual 
ischemic myocardium at risk, the worse the prognosis. While 
different mortality/morbidity rates can be defined for popula-
tion subsets, and statistical significance of these differences cal-
culated, the accurate calculation of a precise risk for a given pa-
tient is not yet possible. 
There is yet another caveat about post-MI risk stratification. 
Using the data in the Figure as a prototype, the issue raised is 
that while specific factors which carry exceedingly high risk for 
mortality or morbidity can be identified (e.g., LV ejection frac-
tion < 20%), the fraction of MI patients that fall into these high-
risk categories is so small that the total number of morbid events 
accounted for by the "high-risk group" represents the minority 
of events that occur in the total MI population. The data from the 
Figure are presented in tabular form in the Table which includes 
a data set for absolute number of deaths accounted for in each 
LV ejection fraction subgroup. From the Table, the following is 
obvious: 1) of 64 total deaths, only 10 (16%) occurred in the 
highest risk group; 2) the two lowest risk subgroups accounted 
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Table 
Mortality Rate and Absolute Numbers of 
Deaths as a Function of LVEF* 
LVEF 
Number of 
Patients 
Mortality 
Rate 
Calculated Number 
of Deaths 
<20% 21 47% 10 
20%-39% 244 12% 29 
40%-59% 382 5% !9 
>60% 152 4% 6 
*Data from the Figure presented in tabular form, 
LVEF = left ventricular ejection fraction. 
for a total of 25 deaths (39%); and 3) depending upon the value 
chosen to represent the true infiection point of the curve de-
picted in the Figure, since the group defined as having LV ejec-
tion fractions in the 20% to 39% range clearly straddles this 
point, it is highly probable that more than 50% of the total deaths 
occurred in patients with a LV ejection fraction > 35%, i.e., a 
subgroup defined as being at low relative risk. When a similar 
analysis is applied to any other stratifying variable in any of a 
number of studies, a similar pattem emerges. Thus, one must 
conclude that presently recognized risk stratification strategies 
do not identify the majority of patients who will experience 
morbidity or mortality in the dangerous interlude that follows 
acute MI. Altematively stated, while it takes no great cardio-
logic wisdom in 1991 to recognize that a post-MI patient with an 
LV ejection fraction of < 20%, high-grade VEA, and poor exer-
cise tolerance is at high risk for cardiac mortality and morbidity, 
it remains frustrating that the majority of patients experiencing 
early post-MI morbidity are relatively healthy in a cardiac sense, 
insofar as our major stratifying variables are concerned. The 
challenge of the future is not only to prolong the life of the pa-
tient with poor LV function and arrhythmia but also to identify 
why and who of the ostensibly healthy post-MI patients will ex-
perience early morbidity or mortalily. 
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